SAFER-OPIOIDS: A structured approach to identifying key information and drug therapy problems in chronic noncancer pain patients using opioid therapy

Canadian Pharmacists Journal

Volumn 146, Issue 1, 2013, Pages 26-29

  Murphy, Laura ^a   Isaac, Pearl ^b   Kalvik, Anne ^b   Ng, Karen ^a   Su, Victoria C H ^a   Sproule, Beth ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; MORPHINE; OPIATE; TRAMADOL;

ANALGESIA; ANOREXIA; ARTICLE; BEHAVIOR; BRIEF PAIN INVENTORY; CHRONIC PAIN; COGNITIVE DEFECT; CONSTIPATION; DEPRESSION; DISEASE EXACERBATION; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG MISUSE; FALLING; FIBROMYALGIA; HEARTBURN; HUMAN; HYPERALGESIA; MENTAL DISEASE; MOOD DISORDER; MORTALITY; NAUSEA; PATIENT COMPLIANCE; PHARMACIST; PHARMACY; PHYSICIAN; PILL; PRESCRIPTION; PRURITUS; QUESTIONNAIRE; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDERED BREATHING; SUBSTANCE ABUSE; SWEATING; URINE RETENTION; VOMITING; XEROSTOMIA;

EID: 84875500100     PISSN: 17151635     EISSN: 1913701X     Source Type: Journal    
DOI: 10.1177/1715163512472310     Document Type: Article

References (15)

1. National Opioid Use Guideline Group (NOUGG). Canadian guideline for safe and effective use of opioids for chronic non-cancer pain. 2010. Available: http://nationalpaincentre.mcmaster.ca/opioid/ (accessed March 9, 2010).
2. Weeks C.High doses of opioids tied to death risk.The Globe and Mail. 2011;:11.
3. Ontario Pharmacists' Association. Recommendations to pharmacists regarding OxyContin substitution. OPA Bulletin. Toronto (ON): Ontario Pharmacists' Association; 2012. Available: www.nlpb.ca/Documents/News_Communications/120227-OPA_OxyContin_notice.pdf (accessed December 4, 2012).
4. Kahan M,Wilson L,Wenghofer EF, et al.Pharmacists' experiences with dispensing opioids.Can Fam Physician. 2011;57:e448-54.
5. Cipolle RJ,Strand L,Morley P.Pharmaceutical care practice: a clinician's guide. 2nd ed. New York (NY): McGraw-Hill Medical; 2004.2004:.
6. Farrar JT,Young JP,LaMoreaux L, et al.Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.Pain. 2001;94:149-58.
7. Gomes T,Mamdani A,Dhalla I, et al.Opioid dose and drug-related mortality in patients with nonmalignant pain.Arch Intern Med. 2011;171:686-91.
8. Hudson (OH): Lexi-Comp, Inc.; 2012:.
9. Furlan A,Chaparro L,Irvin E,Mailis-Gagnon A.A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain.Pain Res Manag. 2011;16:337-51.
10. O'Connor AB,Dworkin RH.Treatment of neuropathic pain: an overview of recent guidelines.Am J Med. 2009;122:S22-32.
11. Bigal M,Lipton R.Excessive opioid use and the development of chronic migraine.Pain. 2009;142:179-82.
12. Goebel JR,Compton P,Zubkoff L, et al.Prescription sharing, alcohol use and street drug use to manage pain among veterans.J Pain Symptom Manage. 2011;41:848-58.
13. Furlan A,Reardon R,Salach L.The opioid manager: a point-of-care tool to facilitate the use of the Canadian Opioid Guideline.J Opioid Manag. 2012;8:57-61.
14. Vincent JL.Give your patient a fast hug (at least) once a day.Crit Care Med. 2005;33:1225-9.
15. Mabasa VH,Malyuk DL,Weatherby E-M,Chan A.A standardized, structured approach to identifying drug-related problems in the intensive care unit: FASTHUG-MAIDENS.Can J Hosp Pharm. 2011;64:366-9.